225 related articles for article (PubMed ID: 22424082)
41. The cancer biomarker problem.
Sawyers CL
Nature; 2008 Apr; 452(7187):548-52. PubMed ID: 18385728
[TBL] [Abstract][Full Text] [Related]
42. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
43. The challenge of intratumour heterogeneity in precision medicine.
Seoane J; De Mattos-Arruda L
J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
[TBL] [Abstract][Full Text] [Related]
44. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?
Roukos DH
Expert Rev Mol Diagn; 2010 Apr; 10(3):247-50. PubMed ID: 20370580
[No Abstract] [Full Text] [Related]
45. Time to adapt.
Nature; 2010 Apr; 464(7293):1245-6. PubMed ID: 20428115
[No Abstract] [Full Text] [Related]
46. Biomarkers and oncology: the path forward to a learning health system.
Yu PP; Hoffman MA; Hayes DF
Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
[No Abstract] [Full Text] [Related]
47. Personalized cancer medicine: from molecular diagnostics to targeted therapy with natural products.
Efferth T
Planta Med; 2010 Aug; 76(11):1143-54. PubMed ID: 20486071
[TBL] [Abstract][Full Text] [Related]
48. Sequencing set to alter clinical landscape.
Hayden EC
Nature; 2012 Feb; 482(7385):288. PubMed ID: 22337027
[No Abstract] [Full Text] [Related]
49. Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.
Stricker T; Catenacci DV; Seiwert TY
Semin Oncol; 2011 Apr; 38(2):173-85. PubMed ID: 21421108
[TBL] [Abstract][Full Text] [Related]
50. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
51. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
52. Enabling personalized cancer medicine through analysis of gene-expression patterns.
van't Veer LJ; Bernards R
Nature; 2008 Apr; 452(7187):564-70. PubMed ID: 18385730
[TBL] [Abstract][Full Text] [Related]
53. Ethics and genomic medicine, how to navigate decisions in surgical oncology.
Devon KM; Lerner-Ellis JP; Ganai S; Angelos P
J Surg Oncol; 2015 Jan; 111(1):18-23. PubMed ID: 25183289
[TBL] [Abstract][Full Text] [Related]
54. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
55. Molecular tumor profiling for prediction of response to anticancer therapies.
Walther Z; Sklar J
Cancer J; 2011; 17(2):71-9. PubMed ID: 21427550
[TBL] [Abstract][Full Text] [Related]
56. Biomarkers in cancer research and treatment: promises and challenges.
Hainaut P; Plymoth A
Curr Opin Oncol; 2011 Jan; 23(1):61. PubMed ID: 21321519
[No Abstract] [Full Text] [Related]
57. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
Buikhuisen WA; Burgers JA; Vincent AD; Schellens JH; Beijnen JH; Smit EF; Joerger M
J Clin Oncol; 2010 Sep; 28(27):e482-3; author reply e484. PubMed ID: 20606096
[No Abstract] [Full Text] [Related]
58. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
Bartelink H
Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
[No Abstract] [Full Text] [Related]
59. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
60. "Personalizing" therapy for non-small cell lung cancer.
D'Cunha J
Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]